Relmada Therapeutics, Inc. (RLMD): S-3 filed Apr 3, 2026

Form type

S-3

Filing date

Apr 3, 2026

Accession number

0001213900-26-039967

Filer

Relmada Therapeutics, Inc. (CIK 1553643)